NCT01510782 - Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy

Interventions

DRUG

Placebo to BI 655064

intravenous infusion of escalating doses

DRUG

Placebo to BI 655064

subcutaneous injection of escalating doses

DRUG

BI 655064

intravenous infusion of escalating doses

DRUG

BI 655064

subcutaneous injection of escalating doses

Trial Locations (1)

1293.1.1 Boehringer Ingelheim Investigational Site, Berlin